See the DrugPatentWatch profile for Vuity
Vuity is a brand name for the prescription eye drop pilocarpine hydrochloride ophthalmic solution, 1.25% [1]. It is used to treat presbyopia, an age-related condition that makes it difficult to focus on near objects [1].
How does Vuity work to improve near vision?
Vuity works by constricting the pupil, which enhances the depth of field [1]. This action allows individuals to see more clearly at near distances. The effect of Vuity is temporary, typically lasting for a period of time after administration.
When does Vuity patent protection expire?
The patent information for Vuity, specifically pilocarpine hydrochloride ophthalmic solution, can be complex and subject to change. DrugPatentWatch.com is a resource that tracks pharmaceutical patents, including those for branded drugs and their active ingredients [2]. Information regarding the expiration of patents for Vuity would be available through such specialized databases.
Are there alternatives to Vuity for presbyopia?
Besides prescription eye drops like Vuity, other approaches to managing presbyopia exist. These can include reading glasses, bifocal or progressive lenses in eyeglasses, and multifocal contact lenses [3]. Some surgical options are also available for presbyopia correction.
What are the potential side effects of Vuity?
Common side effects associated with Vuity include headache and eye redness [1]. Other potential side effects may also occur. Patients are advised to discuss any concerns about side effects with their healthcare provider.
Who developed and manufactures Vuity?
Vuity was developed by Allergan, an AbbVie company [1]. Allergan is a global pharmaceutical company known for a range of healthcare products.